Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology:
ir.anixa.com/press-releas...

Dr. Robert Wenham, principal investigator for Anixa's ongoing ovarian cancer CAR-T therapy Phase 1 clinical trial, will be presenting at the 13th Annual Ovarcoming Cancer Conference, being held September 18 – 19, 2025, at the Briar Club in Houston, Texas.
ir.anixa.com/press-releas...

I have seen this movie before

Example:

Registration for the 12th Annual Southeastern Immunology Symposium in bautiful Charlottesville is now available:

www.immunology.virginia.edu/sis2025/inde...

Patient responding to anti-FSHR CAR Is First To Receive Second CAR T Therapy for Ovarian Cancer

Inaugural AACR IO Conference on Discovery and Innovation in Cancer Immunology, chaired by Antoni Ribas.
February 23-26, 2025, in Los Angeles. Learn more:
bit.ly/3yOlXwm
#AACRIO25